$MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock $mrvi

$mrvi Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000182323922000012 Filed on March 01, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$228.4M	$799.2M	$98.40M
YoY Change	132.16%	181.33%	173.33%
Cost Of Revenue	$40.63M	$140.6M	$23.40M
YoY Change	73.65%	76.48%	31.46%
Gross Profit	$187.8M	$658.7M	$75.00M
YoY Change	150.41%	222.17%	314.36%
Gross Profit Margin	82.21%	82.41%	76.22%
Selling, General & Admin	$27.55M	$100.1M	$41.60M
YoY Change	-33.77%	6.17%	201.45%
% of Gross Profit	14.67%	15.19%	55.47%
Research & Development	$8.573M	$15.22M	$200.0K
YoY Change	4186.5%	63.57%	-80.0%
% of Gross Profit	4.56%	2.31%	0.27%
Depreciation & Amortization	$3.444M	$6.413M	$5.800M
YoY Change	-40.62%	14.66%	-13.43%
% of Gross Profit	1.83%	0.97%	7.73%
Operating Expenses	$36.73M	$115.3M	$43.70M
YoY Change	-15.96%	11.33%	158.58%
Operating Profit	$151.1M	$554.6M	$31.30M
YoY Change	382.7%	362.58%	2508.33%
Interest Expense	-$4.433M	$30.26M	-$8.800M
YoY Change	-49.63%	-1.56%	14.29%
% of Operating Profit	-2.93%	5.46%	-28.12%
Other Income/Expense, Net	-$2.830M	$279.0K	$0.00
YoY Change		121.43%
Pretax Income	$143.8M	$530.8M	$14.80M
YoY Change	871.77%	549.68%	-331.25%
Income Tax	$17.58M	$61.52M	$400.0K
% Of Pretax Income	12.22%	11.59%	2.7%
Net Earnings	$55.44M	$182.0M	$11.43M
YoY Change	385.01%	104.6%	-328.62%
Net Earnings / Revenue	24.27%	22.78%	11.62%
Basic Earnings Per Share		$1.59
Diluted Earnings Per Share	$215.0K	$1.56	$208.0K
COMMON SHARES
Basic Shares Outstanding		114.8M shares
Diluted Shares Outstanding		257.8M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$551.3M	$551.3M	$236.2M
YoY Change	133.39%	133.39%
Cash & Equivalents	$551.3M		$236.2M
Short-Term Investments
Other Short-Term Assets	$19.70M	$19.70M	$10.90M
YoY Change	80.72%	80.72%
Inventory	$51.56M	$51.56M	$33.30M
Prepaid Expenses
Receivables	$117.5M	$117.5M	$51.02M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$740.0M	$740.0M	$331.6M
YoY Change	123.17%	123.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$46.33M	$95.43M	$101.3M
YoY Change	-54.26%	-5.8%
Goodwill	$152.8M		$224.3M
YoY Change	-31.88%
Intangibles	$117.6M		$177.7M
YoY Change	-33.82%
Long-Term Investments
YoY Change
Other Assets	$53.45M	$812.5M	$4.158M
YoY Change	1185.5%	86.39%
Total Long-Term Assets	$1.178B	$1.178B	$939.1M
YoY Change	25.47%	25.46%
TOTAL ASSETS
Total Short-Term Assets	$740.0M	$740.0M	$331.6M
Total Long-Term Assets	$1.178B	$1.178B	$939.1M
Total Assets	$1.918B	$1.918B	$1.271B
YoY Change	50.96%	50.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.154M	$8.154M	$8.171M
YoY Change	-0.21%	-0.56%
Accrued Expenses	$34.57M	$29.34M	$38.55M
YoY Change	-10.3%	1.17%
Deferred Revenue	$10.21M		$78.06M
YoY Change	-86.92%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$6.000M	$6.000M	$6.000M
YoY Change	0.0%	0.0%
Total Short-Term Liabilities	$93.78M	$93.78M	$130.8M
YoY Change	-28.29%	-28.31%
LONG-TERM LIABILITIES
Long-Term Debt	$524.6M	$524.6M	$528.6M
YoY Change	-0.76%	-10.3%
Other Long-Term Liabilities	$41.07M	$754.5M	$2.231M
YoY Change	1740.7%	92.58%
Total Long-Term Liabilities	$565.7M	$1.279B	$530.8M
YoY Change	6.56%	30.98%
TOTAL LIABILITIES
Total Short-Term Liabilities	$93.78M	$93.78M	$130.8M
Total Long-Term Liabilities	$565.7M	$1.279B	$530.8M
Total Liabilities	$1.373B	$1.603B	$1.116B
YoY Change	23.03%	35.58%
SHAREHOLDERS EQUITY
Retained Earnings	$184.6M		$854.0K
YoY Change	21511.36%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$315.5M	$315.5M	$88.51M
YoY Change
Total Liabilities & Shareholders Equity	$1.918B	$1.918B	$1.271B
YoY Change	50.96%	50.96%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	$55.44M	$182.0M	$11.43M
YoY Change	385.01%	104.6%	-328.62%
Depreciation, Depletion And Amortization	$3.444M	$6.413M	$5.800M
YoY Change	-40.62%	14.66%	-13.43%
Cash From Operating Activities	$58.17M	$368.6M	$79.40M
YoY Change	-26.74%	142.18%	763.04%
INVESTING ACTIVITIES
Capital Expenditures	-$5.662M	$14.85M	-$8.800M
YoY Change	-35.66%	-41.55%	87.23%
Acquisitions		$0.00
YoY Change
Other Investing Activities	$0.00	$120.5M	$0.00
YoY Change		249.29%
Cash From Investing Activities	-$5.662M	$105.7M	-$8.800M
YoY Change	-35.66%	1641.18%	87.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net		$6.000M
YoY Change		-98.54%
Cash From Financing Activities	-49.00M	-$159.0M	40.70M
YoY Change	-220.39%	-398.9%
NET CHANGE
Cash From Operating Activities	58.17M	$368.6M	79.40M
Cash From Investing Activities	-5.662M	$105.7M	-8.800M
Cash From Financing Activities	-49.00M	-$159.0M	40.70M
Net Change In Cash	3.507M	$315.1M	111.3M
YoY Change	-96.85%	48.99%	2373.33%
FREE CASH FLOW
Cash From Operating Activities	$58.17M	$368.6M	$79.40M
Capital Expenditures	-$5.662M	$14.85M	-$8.800M
Free Cash Flow	$63.83M	$353.7M	$88.20M
YoY Change	-27.63%	179.01%	534.53%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001823239
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	3744800000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2018	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201409Member
CY2020	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201602Member
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-39725
CY2021	dei	Entity Registrant Name EntityRegistrantName	Maravai LifeSciences Holdings, Inc.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-2786970
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	10770 Wateridge Circle
CY2021	dei	Security12b Title Security12bTitle	Class A common stock, $0.01 par value
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92121
CY2021	dei	City Area Code CityAreaCode	858
CY2021	dei	Local Phone Number LocalPhoneNumber	546-0004
CY2021	dei	Trading Symbol TradingSymbol	MRVI
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2020Q4	us-gaap	Assets Current AssetsCurrent	331598000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	51557000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	33301000	USD
CY2021	dei	Auditor Firm AuditorFirmId	42
CY2021Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	748300000	USD
CY2021	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2021	dei	Auditor Location AuditorLocation	Redwood City, California
CY2021Q4	us-gaap	Cash Cash	551272000	USD
CY2020Q4	us-gaap	Cash Cash	236184000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	117512000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	51018000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19698000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	11095000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	740039000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	38546000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8154000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8171000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	34574000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	46332000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	101305000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	152766000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	224275000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	117571000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	177656000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	808117000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	431699000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	53451000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4158000	USD
CY2021Q4	us-gaap	Assets Assets	1918276000	USD
CY2020Q4	us-gaap	Assets Assets	1270691000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10211000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	78061000	USD
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	34838000	USD
CY2020Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	0	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6000000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6000000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	93777000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	130778000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	524591000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	528614000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	8609000	USD
CY2020Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	56167000	USD
CY2021Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	713481000	USD
CY2020Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	389546000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	41066000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2231000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	1372915000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	1115945000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	128386000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	85125000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	184561000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	854000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-44000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	315499000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	88511000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	229862000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	66235000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	545361000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	154746000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1918276000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1270691000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	799240000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	284098000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	143140000	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	140561000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	79649000	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	66849000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15219000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9304000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3627000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	100064000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	94245000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	48354000	USD
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	322000	USD
CY2021	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	11249000	USD
CY2020	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2019	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2021	us-gaap	Sale Leaseback Transaction Current Period Gain Recognized SaleLeasebackTransactionCurrentPeriodGainRecognized	0	USD
CY2020	us-gaap	Sale Leaseback Transaction Current Period Gain Recognized SaleLeasebackTransactionCurrentPeriodGainRecognized	19002000	USD
CY2019	us-gaap	Sale Leaseback Transaction Current Period Gain Recognized SaleLeasebackTransactionCurrentPeriodGainRecognized	0	USD
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	244595000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	164196000	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	119152000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	554645000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	119902000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	23988000	USD
CY2021	us-gaap	Interest Expense InterestExpense	30260000	USD
CY2020	us-gaap	Interest Expense InterestExpense	30740000	USD
CY2019	us-gaap	Interest Expense InterestExpense	29959000	USD
CY2021	us-gaap	Related Party Tax Expense Effect Of Change In Allocation Methodology RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology	-6101000	USD
CY2020	us-gaap	Related Party Tax Expense Effect Of Change In Allocation Methodology RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology	0	USD
CY2019	us-gaap	Related Party Tax Expense Effect Of Change In Allocation Methodology RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology	0	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-7592000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-10156000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	279000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	126000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	118000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	530765000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	81696000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5853000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61515000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2880000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-652000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	469250000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	78816000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-5201000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	287213000	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-731000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	182037000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	88972000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-4470000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.59
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	7.43
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.56
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.36
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	114791000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10351000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	253917000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	257803000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28908000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	253917000	shares
CY2021	us-gaap	Profit Loss ProfitLoss	469250000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	78816000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-5201000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	55000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-44000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	34000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	469305000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	78772000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-5167000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	287224000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-10156000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-731000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	182081000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	88928000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4436000	USD
CY2018Q4	us-gaap	Members Equity MembersEquity	148016000	USD
CY2019	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	227000	USD
CY2019	us-gaap	Limited Liability Company Llc Members Equity Unit Based Compensation LimitedLiabilityCompanyLLCMembersEquityUnitBasedCompensation	1679000	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	9140000	USD
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	88880000	USD
	us-gaap	Limited Liability Company Llc Members Equity Unit Based Compensation LimitedLiabilityCompanyLLCMembersEquityUnitBasedCompensation	3276000	USD
	us-gaap	Profit Loss ProfitLoss	88216000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-5201000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	34000	USD
CY2019Q4	us-gaap	Members Equity MembersEquity	144627000	USD
	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	166427000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1000	USD
CY2020Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1754432000	USD
CY2020Q4	mrvi	Noncontrolling Interest Decrease From Purchase Of Preexisting Units NoncontrollingInterestDecreaseFromPurchaseOfPreexistingUnits	1424327000	USD
CY2020Q4	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	0	USD
CY2020Q4	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	33658000	USD
CY2020Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	20387000	USD
CY2020Q4	us-gaap	Profit Loss ProfitLoss	-20831000	USD
CY2020Q4	mrvi	Adjustments To Additional Paid In Capital Tax Receivable Agreement Impact AdjustmentsToAdditionalPaidInCapitalTaxReceivableAgreementImpact	42776000	USD
CY2020Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	966000	USD
CY2020Q4	us-gaap	Profit Loss ProfitLoss	11431000	USD
CY2020Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	16000	USD
CY2020Q4	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	8171000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	154746000	USD
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	0	USD
CY2021	mrvi	Adjustments To Additional Paid In Capital Tax Receivable Agreement Impact AdjustmentsToAdditionalPaidInCapitalTaxReceivableAgreementImpact	53000000	USD
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1670000	USD
CY2021	mrvi	Noncontrolling Interest Increase From Cash Distribution Value NoncontrollingInterestIncreaseFromCashDistributionValue	5220000	USD
CY2021	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	0	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10458000	USD
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	153492000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	469250000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	55000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	545361000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	469250000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	78816000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20274000	USD
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	8792000	USD
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-5201000	USD
CY2021	mrvi	Depreciation Including Adjustments DepreciationIncludingAdjustments	6413000	USD
CY2020	mrvi	Depreciation Including Adjustments DepreciationIncludingAdjustments	5517000	USD
CY2019	mrvi	Depreciation Including Adjustments DepreciationIncludingAdjustments	3810000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	18339000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20320000	USD
CY2019	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	USD
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2676000	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1825000	USD
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1734000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	10458000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	24629000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	1679000	USD
CY2020	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2019	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2021	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	11249000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-7592000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	46904000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-5464000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1159000	USD
CY2021	us-gaap	Sale And Leaseback Transaction Gain Loss Net SaleAndLeasebackTransactionGainLossNet	0	USD
CY2020	us-gaap	Sale Leaseback Transaction Current Period Gain Recognized SaleLeasebackTransactionCurrentPeriodGainRecognized	19002000	USD
CY2019	us-gaap	Sale Leaseback Transaction Current Period Gain Recognized SaleLeasebackTransactionCurrentPeriodGainRecognized	0	USD
CY2021	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
CY2020	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	2881000	USD
CY2019	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
CY2021	mrvi	Payments Of Financing Costs Operating Activities PaymentsOfFinancingCostsOperatingActivities	0	USD
CY2020	mrvi	Payments Of Financing Costs Operating Activities PaymentsOfFinancingCostsOperatingActivities	3239000	USD
CY2019	mrvi	Payments Of Financing Costs Operating Activities PaymentsOfFinancingCostsOperatingActivities	0	USD
CY2021	mrvi	Gain Loss On Tax Receivable Agreement GainLossOnTaxReceivableAgreement	6101000	USD
CY2020	mrvi	Gain Loss On Tax Receivable Agreement GainLossOnTaxReceivableAgreement	0	USD
CY2019	mrvi	Gain Loss On Tax Receivable Agreement GainLossOnTaxReceivableAgreement	0	USD
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	281000	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-2419000	USD
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-688000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	70391000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	33144000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1888000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	21574000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	19099000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-106000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	9513000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5518000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1983000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	676000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1176000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2470000	USD
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3457000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	17777000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3505000	USD
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-4521000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-2519000	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	USD
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-67851000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	77220000	USD
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	80000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	368570000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	152187000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	24115000	USD
CY2021	mrvi	Payments To Acquire Assets Net Of Cash Acquired PaymentsToAcquireAssetsNetOfCashAcquired	0	USD
CY2020	mrvi	Payments To Acquire Assets Net Of Cash Acquired PaymentsToAcquireAssetsNetOfCashAcquired	3024000	USD
CY2019	mrvi	Payments To Acquire Assets Net Of Cash Acquired PaymentsToAcquireAssetsNetOfCashAcquired	0	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14850000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	25408000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	17148000	USD
CY2021	us-gaap	Proceeds From Sale Of Buildings ProceedsFromSaleOfBuildings	548000	USD
CY2020	us-gaap	Proceeds From Sale Of Buildings ProceedsFromSaleOfBuildings	34500000	USD
CY2019	us-gaap	Proceeds From Sale Of Buildings ProceedsFromSaleOfBuildings	0	USD
CY2021	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	119957000	USD
CY2020	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	0	USD
CY2019	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	105655000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	6068000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17148000	USD
CY2021	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	153451000	USD
CY2020	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	97051000	USD
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	411875000	USD
CY2019	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	0	USD
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	609000000	USD
CY2019	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	9295000	USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2021	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	0	USD
CY2020	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	9140000	USD
CY2019	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	227000	USD
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	6000000	USD
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2500000	USD
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	USD
CY2020	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	1439000	USD
CY2019	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	1300000	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	33658000	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	USD
CY2020	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	201000	USD
CY2019	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	140000	USD
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
CY2020	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	120005000	USD
CY2019	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
CY2021	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	0	USD
CY2020	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	208053000	USD
CY2019	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	0	USD
CY2021	mrvi	Payments To Acquire Limited Liability Company Units PaymentsToAcquireLimitedLiabilityCompanyUnits	0	USD
CY2020	mrvi	Payments To Acquire Limited Liability Company Units PaymentsToAcquireLimitedLiabilityCompanyUnits	1424324000	USD
CY2019	mrvi	Payments To Acquire Limited Liability Company Units PaymentsToAcquireLimitedLiabilityCompanyUnits	0	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2021	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1709000	USD
CY2020	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	321000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	27234000	USD
CY2019	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-159049000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	53212000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4167000	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-88000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	315088000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	211484000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2834000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	236184000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24700000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21866000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	551272000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	236184000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24700000	USD
CY2021	mrvi	Capitalized Costs Under Lease Financing Transaction CapitalizedCostsUnderLeaseFinancingTransaction	0	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	28916000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	28728000	USD
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	22473000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	5006000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	802000	USD
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2149000	USD
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1990000	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2765000	USD
CY2021	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
CY2020	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	6000000	USD
CY2019	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
CY2020	mrvi	Capitalized Costs Under Lease Financing Transaction CapitalizedCostsUnderLeaseFinancingTransaction	700000	USD
CY2019	mrvi	Capitalized Costs Under Lease Financing Transaction CapitalizedCostsUnderLeaseFinancingTransaction	51200000	USD
CY2021	mrvi	Capital Expenditures Incurred But Not Yet Paid Capital Leases CapitalExpendituresIncurredButNotYetPaidCapitalLeases	0	USD
CY2020	mrvi	Capital Expenditures Incurred But Not Yet Paid Capital Leases CapitalExpendituresIncurredButNotYetPaidCapitalLeases	0	USD
CY2019	mrvi	Capital Expenditures Incurred But Not Yet Paid Capital Leases CapitalExpendituresIncurredButNotYetPaidCapitalLeases	15000	USD
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2020	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	46422000	USD
CY2019	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2021	mrvi	Conversion Of Stock Amount Converted For Blocker Mergers ConversionOfStockAmountConvertedForBlockerMergers	0	USD
CY2020	mrvi	Conversion Of Stock Amount Converted For Blocker Mergers ConversionOfStockAmountConvertedForBlockerMergers	782073000	USD
CY2019	mrvi	Conversion Of Stock Amount Converted For Blocker Mergers ConversionOfStockAmountConvertedForBlockerMergers	0	USD
CY2021	mrvi	Conversion Of Stock Deferred Tax Asset ConversionOfStockDeferredTaxAsset	423361000	USD
CY2020	mrvi	Conversion Of Stock Deferred Tax Asset ConversionOfStockDeferredTaxAsset	441984000	USD
CY2019	mrvi	Conversion Of Stock Deferred Tax Asset ConversionOfStockDeferredTaxAsset	0	USD
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	366179000	USD
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	389546000	USD
CY2019	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	0	USD
CY2021	mrvi	Stock Issuance Costs Incurred During Noncash Or Partial Noncash Transaction StockIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
CY2020	mrvi	Stock Issuance Costs Incurred During Noncash Or Partial Noncash Transaction StockIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	2816000	USD
CY2019	mrvi	Stock Issuance Costs Incurred During Noncash Or Partial Noncash Transaction StockIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
CY2021	mrvi	Noncash Or Part Noncash Divestiture Receivable From Lessor Funded Financing NoncashOrPartNoncashDivestitureReceivableFromLessorFundedFinancing	0	USD
CY2020	mrvi	Noncash Or Part Noncash Divestiture Receivable From Lessor Funded Financing NoncashOrPartNoncashDivestitureReceivableFromLessorFundedFinancing	1987000	USD
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	284098000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	143140000	USD
CY2019	mrvi	Noncash Or Part Noncash Divestiture Receivable From Lessor Funded Financing NoncashOrPartNoncashDivestitureReceivableFromLessorFundedFinancing	0	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in accordance with GAAP requires the Company to make judgements, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenue and expenses, and related disclosures. These estimates form the basis for judgments the Company makes about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company bases its estimates and judgments on historical experience and on various other assumptions that the Company believes are reasonable under the circumstances. These estimates are based on management’s knowledge about current events and expectations about actions the Company may undertake in the future. Significant estimates include, but are not limited to, the measurement of right-of-use assets and lease liabilities and related incremental borrowing rate, the payable to related parties pursuant to the Tax Receivable Agreement, and the realizability of our net deferred tax assets. Actual results could differ materially from those estimates.</span></div>
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	12600000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	79200000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	799240000	USD
CY2021	us-gaap	Advertising Expense AdvertisingExpense	1300000	USD
CY2020	us-gaap	Advertising Expense AdvertisingExpense	1200000	USD
CY2019	us-gaap	Advertising Expense AdvertisingExpense	1100000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1	P4Y
CY2021	mrvi	Tax Receivable Agreement Percentage Of Tax Benefits Paid TaxReceivableAgreementPercentageOfTaxBenefitsPaid	0.85
CY2021	mrvi	Tax Receivable Agreement Percentage Of Tax Benefits Unpaid TaxReceivableAgreementPercentageOfTaxBenefitsUnpaid	0.15
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	400000	USD
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	300000	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentration of Credit RiskFinancial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and accounts receivable. The Company maintains the majority of its cash balances at multiple financial institutions that management believes are of high-credit quality and financially stable. Cash is deposited with major financial institutions in excess of Federal Deposit Insurance Corporation (“FDIC”) insurance limits. The Company believes it is not exposed to significant credit risk due to the financial strength of the depository institutions in which the cash is held. The Company provides credit, in the normal course of business, to international and domestic distributors as well as certain customers, which are geographically dispersed. The Company attempts to limit its credit risk by performing ongoing credit evaluations of its customers and maintaining adequate allowances for potential credit losses.
CY2021Q4	us-gaap	Goodwill Goodwill	152800000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	224300000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2231000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	854000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	11095000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	101305000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	431699000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4158000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	38546000	USD
CY2020Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	56167000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	66235000	USD
CY2021	us-gaap	Number Of Reporting Units NumberOfReportingUnits	3	reporting_unit
CY2020	us-gaap	Number Of Reporting Units NumberOfReportingUnits	4	reporting_unit
CY2021	us-gaap	Number Of Reporting Units NumberOfReportingUnits	3	reporting_unit
CY2021	us-gaap	Number Of Reporting Units NumberOfReportingUnits	3	reporting_unit
CY2020Q4	us-gaap	Goodwill Goodwill	224275000	USD
CY2021	us-gaap	Goodwill Transfers GoodwillTransfers	-71509000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	152766000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	194721000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	77150000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	117571000	USD
CY2021	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P8Y1M6D
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	264217000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	86561000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	177656000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	45529000	USD
CY2020	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P9Y1M6D
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	14600000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	14417000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	14417000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	14417000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	14191000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	117571000	USD
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	19726000	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	11112000	USD
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	21382000	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	18333000	USD
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	10449000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	3856000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	51557000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	33301000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12532000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10647000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	46332000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	101305000	USD
CY2021	us-gaap	Depreciation Depreciation	6400000	USD
CY2020	us-gaap	Depreciation Depreciation	5600000	USD
CY2019	us-gaap	Depreciation Depreciation	3800000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	18894000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	18448000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3722000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	USD
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2897000	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	7670000	USD
CY2021Q4	mrvi	Contract With Customer Liability Current Customer Deposits ContractWithCustomerLiabilityCurrentCustomerDeposits	2429000	USD
CY2020Q4	mrvi	Contract With Customer Liability Current Customer Deposits ContractWithCustomerLiabilityCurrentCustomerDeposits	1091000	USD
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1296000	USD
CY2020Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2896000	USD
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	102000	USD
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2290000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5234000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6151000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	34574000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	38546000	USD
CY2020Q1	us-gaap	Sale Leaseback Transaction Gross Proceeds Investing Activities SaleLeasebackTransactionGrossProceedsInvestingActivities	34500000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	49095000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3722000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	40906000	USD
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	8792000	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	1759000	USD
CY2021	us-gaap	Lease Cost LeaseCost	10551000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y2M12D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.051
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	6335000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	5904000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	6354000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	6535000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	6521000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	6604000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	23342000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	55260000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	10632000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	44628000	USD
CY2020	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	3200000	USD
CY2019	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2500000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	2777000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	400000000	USD
CY2020Q4	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	50000000	USD
CY2018Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	52000000	USD
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	544000000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	550000000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	3062000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1336000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1371000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1104000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	5286000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	14936000	USD
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	13409000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	15386000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	530591000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	534614000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6000000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6000000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	524591000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	528614000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	6000000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	6000000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	6000000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	6000000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	6000000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	514000000	USD
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	544000000	USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	mrvi	Noncontrolling Interest Common Units Acquired NoncontrollingInterestCommonUnitsAcquired	2732919	shares
CY2021Q4	mrvi	Noncontrolling Interest Common Units Acquired Price Per Share NoncontrollingInterestCommonUnitsAcquiredPricePerShare	40.25
CY2021Q4	mrvi	Noncontrolling Interest Common Unit Forfeiture Percentage NoncontrollingInterestCommonUnitForfeiturePercentage	0.02036
CY2021	mrvi	Preferred Units Cumulative Annual Dividend Percentage PreferredUnitsCumulativeAnnualDividendPercentage	0.080
CY2021	mrvi	Preferred Units Cumulative Annual Dividend Additional Rate Percentage PreferredUnitsCumulativeAnnualDividendAdditionalRatePercentage	0.040
CY2021	mrvi	Preferred Units Cumulative Annual Dividend Additional Rate Percentage PreferredUnitsCumulativeAnnualDividendAdditionalRatePercentage	0.040
CY2021	us-gaap	Profit Loss ProfitLoss	469250000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	78816000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-5201000	USD
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	USD
CY2020	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	15270000	USD
CY2019	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	5681000	USD
CY2021	mrvi	Net Income Loss Attributable To Common Noncontrolling Interest NetIncomeLossAttributableToCommonNoncontrollingInterest	287213000	USD
CY2020	mrvi	Net Income Loss Attributable To Common Noncontrolling Interest NetIncomeLossAttributableToCommonNoncontrollingInterest	-13342000	USD
CY2019	mrvi	Net Income Loss Attributable To Common Noncontrolling Interest NetIncomeLossAttributableToCommonNoncontrollingInterest	-2396000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	182037000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	76888000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8486000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	182037000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	76888000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8486000	USD
CY2021	us-gaap	Dilutive Securities DilutiveSecurities	132000	USD
CY2020	us-gaap	Dilutive Securities DilutiveSecurities	0	USD
CY2019	us-gaap	Dilutive Securities DilutiveSecurities	0	USD
CY2021	mrvi	Dilutive Securities Effect On Basic Earnings Per Share Conversion Of Class B Common Stock DilutiveSecuritiesEffectOnBasicEarningsPerShareConversionOfClassBCommonStock	220187000	USD
CY2020	mrvi	Dilutive Securities Effect On Basic Earnings Per Share Conversion Of Class B Common Stock DilutiveSecuritiesEffectOnBasicEarningsPerShareConversionOfClassBCommonStock	-8802000	USD
CY2019	mrvi	Dilutive Securities Effect On Basic Earnings Per Share Conversion Of Class B Common Stock DilutiveSecuritiesEffectOnBasicEarningsPerShareConversionOfClassBCommonStock	0	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	402356000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	68086000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8486000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	114791000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10351000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	253917000	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.59
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	7.43
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	114791000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10351000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	253917000	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	153000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1000	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021	mrvi	Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Common Stock IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfCommonStock	142859000	shares
CY2020	mrvi	Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Common Stock IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfCommonStock	18556000	shares
CY2019	mrvi	Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Common Stock IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfCommonStock	0	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	257803000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28908000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	253917000	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.56
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.36
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	367000	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1586000	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14245000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	28.80
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1514000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	26.98
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y10M24D
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	1621000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	454000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	39.98
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	27.00
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	554000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1409000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	30.47
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	16846000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	282000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	26.98
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y9M18D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	4200000	USD
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	4300000	USD
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	18000000	USD
CY2020Q4	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	1000	shares
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10458000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	24629000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1679000	USD
CY2020	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	166400000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	530853000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2880000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-652000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-5464000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1159000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	82012000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-5581000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-88000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-316000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-272000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	530765000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	81696000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5853000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	9291000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	6093000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	505000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1623000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	8344000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	507000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	36564000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-3922000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1224000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2251000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2000	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	3697000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	14611000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	10340000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1542000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	65000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	46904000	USD
CY2021	mrvi	Effective Income Tax Rate Reconciliation Deferred Tax Revaluation Percent EffectiveIncomeTaxRateReconciliationDeferredTaxRevaluationPercent	0
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61515000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.022
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.003
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.011
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	mrvi	Effective Income Tax Rate Reconciliation Deferred Tax Revaluation Percent EffectiveIncomeTaxRateReconciliationDeferredTaxRevaluationPercent	-0.018
CY2019	mrvi	Effective Income Tax Rate Reconciliation Deferred Tax Revaluation Percent EffectiveIncomeTaxRateReconciliationDeferredTaxRevaluationPercent	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.114
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.189
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1249000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	6110000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	831197000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.111
CY2021	mrvi	Effective Income Tax Rate Reconciliation Gain On Liquidation Of Subsidiary Percent EffectiveIncomeTaxRateReconciliationGainOnLiquidationOfSubsidiaryPercent	-0.007
CY2020	mrvi	Effective Income Tax Rate Reconciliation Gain On Liquidation Of Subsidiary Percent EffectiveIncomeTaxRateReconciliationGainOnLiquidationOfSubsidiaryPercent	0.027
CY2019	mrvi	Effective Income Tax Rate Reconciliation Gain On Liquidation Of Subsidiary Percent EffectiveIncomeTaxRateReconciliationGainOnLiquidationOfSubsidiaryPercent	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.001
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.013
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.008
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.004
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.001
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.009
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0.025
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.001
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	448094000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	23080000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13663000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	808117000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.015
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.007
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.005
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.003
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.116
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.035
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.111
CY2021Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	675855000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	360861000	USD
CY2021Q4	mrvi	Deferred Tax Assets Deductions For Tax Receivable Agreement DeferredTaxAssetsDeductionsForTaxReceivableAgreement	154093000	USD
CY2020Q4	mrvi	Deferred Tax Assets Deductions For Tax Receivable Agreement DeferredTaxAssetsDeductionsForTaxReceivableAgreement	81123000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	220000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	434431000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	0	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	11341000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	0	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	11341000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	808117000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	423090000	USD
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	9400000	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	12100000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	208000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	105000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	220000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	136000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	232000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	62000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	5000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	211000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	50000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	38000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	241000	USD
CY2020Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	389500000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	208000	USD
CY2021	mrvi	Tax Receivable Agreement Percentage Of Tax Benefits Paid TaxReceivableAgreementPercentageOfTaxBenefitsPaid	0.85
CY2020Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	389500000	USD
CY2021	mrvi	Gain Loss On Tax Receivable Agreement GainLossOnTaxReceivableAgreement	6100000	USD
CY2021	mrvi	Tax Receivable Agreement Percentage Of Tax Benefits Paid TaxReceivableAgreementPercentageOfTaxBenefitsPaid	0.85
CY2021Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	748300000	USD
CY2021	mrvi	Assumed Effective Income Tax Rate Reconciliation Percent AssumedEffectiveIncomeTaxRateReconciliationPercent	0.467
CY2021	mrvi	Assumed Effective Income Tax Rate Reconciliation Business Income Deduction Unavailable Percent AssumedEffectiveIncomeTaxRateReconciliationBusinessIncomeDeductionUnavailablePercent	0.541
CY2021Q4	mrvi	Tax Distribution Payable TaxDistributionPayable	0	USD
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.50
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.06
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1300000	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1000000	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1200000	USD
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	799240000	USD
CY2021	mrvi	Adjusted Earnings Before Interest Taxes Depreciation And Amortization AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization	582820000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	284098000	USD
CY2020	mrvi	Adjusted Earnings Before Interest Taxes Depreciation And Amortization AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization	169165000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	143140000	USD
CY2019	mrvi	Adjusted Earnings Before Interest Taxes Depreciation And Amortization AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization	62014000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	469250000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	78816000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-5201000	USD
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	18339000	USD
CY2020	us-gaap	Adjustment For Amortization AdjustmentForAmortization	20320000	USD
CY2019	us-gaap	Adjustment For Amortization AdjustmentForAmortization	20274000	USD
CY2021	us-gaap	Depreciation Depreciation	6413000	USD
CY2020	us-gaap	Depreciation Depreciation	5593000	USD
CY2019	us-gaap	Depreciation Depreciation	3810000	USD
CY2021	us-gaap	Interest Expense InterestExpense	30260000	USD
CY2020	us-gaap	Interest Expense InterestExpense	30740000	USD
CY2019	us-gaap	Interest Expense InterestExpense	29959000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61515000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2880000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-652000	USD
CY2021	mrvi	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	585777000	USD
CY2020	mrvi	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	138349000	USD
CY2019	mrvi	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	48190000	USD
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	322000	USD
CY2021	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	44000	USD
CY2020	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	3857000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1679000	USD
CY2021	us-gaap	Management Fee Expense ManagementFeeExpense	0	USD
CY2019	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	6170000	USD
CY2021	mrvi	Amortization Of Purchase Accounting Inventory Step Up AmortizationOfPurchaseAccountingInventoryStepUp	0	USD
CY2020	mrvi	Amortization Of Purchase Accounting Inventory Step Up AmortizationOfPurchaseAccountingInventoryStepUp	0	USD
CY2019	mrvi	Amortization Of Purchase Accounting Inventory Step Up AmortizationOfPurchaseAccountingInventoryStepUp	1856000	USD
CY2021	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
CY2020	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	2881000	USD
CY2019	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10458000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	24629000	USD
CY2020	us-gaap	Management Fee Expense ManagementFeeExpense	680000	USD
CY2019	us-gaap	Management Fee Expense ManagementFeeExpense	523000	USD
CY2021	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	11249000	USD
CY2020	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2019	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2020	us-gaap	Sale Leaseback Transaction Current Period Gain Recognized SaleLeasebackTransactionCurrentPeriodGainRecognized	19002000	USD
CY2021	mrvi	Gain Loss On Tax Receivable Agreement GainLossOnTaxReceivableAgreement	6101000	USD
CY2020	mrvi	Gain Loss On Tax Receivable Agreement GainLossOnTaxReceivableAgreement	0	USD
CY2021	us-gaap	Sale Leaseback Transaction Current Period Gain Recognized SaleLeasebackTransactionCurrentPeriodGainRecognized	0	USD
CY2019	us-gaap	Sale Leaseback Transaction Current Period Gain Recognized SaleLeasebackTransactionCurrentPeriodGainRecognized	0	USD
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1508000	USD
CY2020	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	395000	USD
CY2019	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	3274000	USD
CY2021	us-gaap	Professional Fees ProfessionalFees	2383000	USD
CY2020	us-gaap	Professional Fees ProfessionalFees	9784000	USD
CY2019	us-gaap	Professional Fees ProfessionalFees	0	USD
CY2019	mrvi	Gain Loss On Tax Receivable Agreement GainLossOnTaxReceivableAgreement	0	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-7592000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	mrvi	Adjusted Earnings Before Interest Taxes Depreciation And Amortization AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization	582820000	USD
CY2020	mrvi	Adjusted Earnings Before Interest Taxes Depreciation And Amortization AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization	169165000	USD
CY2019	mrvi	Adjusted Earnings Before Interest Taxes Depreciation And Amortization AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization	62014000	USD

Files In Submission

Name	View Source	Status
0001823239-22-000012-index-headers.html	Edgar Link	pending
0001823239-22-000012-index.html	Edgar Link	pending
0001823239-22-000012.txt	Edgar Link	pending
0001823239-22-000012-xbrl.zip	Edgar Link	pending
exhibit23-voyagerclosingst.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mrvi-20211231.htm	Edgar Link	pending
mrvi-20211231.xsd	Edgar Link	pending
mrvi-20211231_cal.xml	Edgar Link	unprocessable
mrvi-20211231_def.xml	Edgar Link	unprocessable
mrvi-20211231_g1.jpg	Edgar Link	pending
mrvi-20211231_g2.jpg	Edgar Link	pending
mrvi-20211231_g3.jpg	Edgar Link	pending
mrvi-20211231_g4.jpg	Edgar Link	pending
mrvi-20211231_g5.jpg	Edgar Link	pending
mrvi-20211231_g6.jpg	Edgar Link	pending
mrvi-20211231_g7.jpg	Edgar Link	pending
mrvi-20211231_g8.jpg	Edgar Link	pending
mrvi-20211231_g9.jpg	Edgar Link	pending
mrvi-20211231_htm.xml	Edgar Link	completed
mrvi-20211231_lab.xml	Edgar Link	unprocessable
mrvi-20211231_pre.xml	Edgar Link	unprocessable
mrvi-2021form10xkxex211xli.htm	Edgar Link	pending
mrvi-2021form10xkxex231xco.htm	Edgar Link	pending
mrvi-2021form10xkxex311xce.htm	Edgar Link	pending
mrvi-2021form10xkxex321xce.htm	Edgar Link	pending
mrvi-2021form10xkxex322xcf.htm	Edgar Link	pending
mrvi-2021form10xkxex42xdes.htm	Edgar Link	pending
mrvi-form202110xkxex312xcf.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock $mrvi

2021 Q4 Form 10-K Financial Statement

#000182323922000012 Filed on March 01, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. Stock $mrvi

2021 Q4 Form 10-K Financial Statement

#000182323922000012 Filed on March 01, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock $mrvi